A novel approach to first‐trimester screening for early pre‐eclampsia combining serum PP‐13 and Doppler ultrasound
Open Access
- 22 December 2005
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 27 (1), 13-17
- https://doi.org/10.1002/uog.2686
Abstract
Objective To investigate the value of maternal serum placental protein 13 (PP‐13) measurement and uterine artery Doppler during first‐trimester screening in the prediction of early pre‐eclampsia. Methods This was a nested case‐control prospective study of pregnancies at 11 + 0 to 13 + 6 weeks of gestation. The pulsatility index (PI) of blood flow in the uterine arteries and the maternal serum concentration of PP‐13 were measured in 10 women who went on to develop pre‐eclampsia that necessitated delivery before 34 weeks, and in 423 unaffected women. Results were expressed as multiples of the gestation‐specific median in controls (MoM). A logistic regression model was used to predict detection and false‐positive rates. Results In the cases that developed pre‐eclampsia requiring delivery before 34 weeks, compared with the unaffected pregnancies, the median uterine artery PI was higher (1.43 MoM) and the median serum PP‐13 level was lower (0.07 MoM; P < 0.001, Wilcoxon rank sum test for both). Modeling predicted that for a 90% detection rate of pre‐eclampsia requiring delivery before 34 weeks, the false‐positive rate of screening by PP‐13 was 12%, by uterine artery PI was 31% and by a combination of the two methods was 9%. A policy of contingency screening, whereby all women are screened by maternal serum PP‐13 and only the 14% at highest risk are then screened by Doppler, achieved a detection rate of 90% with an overall false‐positive rate of 6%. Conclusion Effective screening for pre‐eclampsia requiring delivery before 34 weeks can potentially be provided by assessment of a combination of maternal serum PP‐13 and uterine artery Doppler in the first trimester of pregnancy. Copyright © 2005 ISUOG. Published by John Wiley & Sons, Ltd.Keywords
This publication has 16 references indexed in Scilit:
- Contingent screening for Down syndrome is an efficient alternative to non‐disclosure sequential screeningPrenatal Diagnosis, 2004
- Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnanciesPlacenta, 2004
- Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestationUltrasound in Obstetrics & Gynecology, 2003
- An increase in cost‐effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testingPrenatal Diagnosis, 2002
- Low dose acetylsalicylic acid in prevention of pregnancy‐induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notchesBJOG: An International Journal of Obstetrics and Gynaecology, 2002
- Second-trimester uterine artery Doppler screening in unselected populations: a reviewThe Journal of Maternal-Fetal & Neonatal Medicine, 2002
- Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestationUltrasound in Obstetrics & Gynecology, 2001
- Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13)Protein Engineering, Design and Selection, 2001
- The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Hypertension in Pregnancy, 2001
- Placental bed spiral arteries in the hypertensive disorders of pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1991